Pharmacogenetics analyzes drug metabolism enzyme (DME) and transporter genes for a clearer look at patients and how their bodies may metabolize certain pharmaceuticals, as well as possible reactions to drug interactions. For hospitals, the repercussions of this emerging practice can be staggering. Doctors with a clearer view of what to expect in their individual patients – many of them who may be in critical condition – save essential time in determining which treatment plans to consider and which to ignore. Imagine the number of lives that could be saved when hypotheticals are reduced. With more foresight, patients receive better care, faster. And in hospitals, efficiency and effectiveness are equally high priorities.
Gulfstream Diagnostics’ pharmacogenetics lab is COLA-compliant and recognized, utilizing the latest QuantStudio™ Flex equipment. Pre-amplification and amplification are separated into two different rooms with the air flow heavily controlled to minimize the risk of contamination. All circuits are 220 volts to prevent electrical overloads from compromising results.
We also offer urine drug testing (UDT), with comprehensive analysis available for over 100 illicit drugs. Our staff is committed to staying on top of the latest developments and updating our liquid chromatography tandem mass spectrometers and other instruments to accommodate them. If you have any questions about pharmacogenetics or UDT and their possible roles in shaping your hospital’s practices, feel free to reach out to us. We are happy to discuss our processes and what they can do for both you and your patients.